News Focus
News Focus
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 2491

Wednesday, 04/30/2008 5:23:14 PM

Wednesday, April 30, 2008 5:23:14 PM

Post# of 3757
IDIX will present IDX899 phase-1/2
monotherapy data from all dosing cohorts at:

ESCMID – Mechanisms of Antimicrobial Resistance
June 15-21, 2008
Palma de Mallorca, Spain
http://www.escmid.org

Top-line data from the 800mg (highest) dose were disclosed in a PR on 2/6/08.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”